Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. 2022;18(9):525–39.

Article  PubMed  PubMed Central  Google Scholar 

Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106–16.

Article  PubMed  Google Scholar 

Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep. 2017;7(1):13461.

Article  PubMed  PubMed Central  Google Scholar 

Moradi Y, Baradaran HR, Djalalinia S, Chinekesh A, Khamseh ME, Dastoorpoor M, et al. Complications of type 2 diabetes in Iranian population: An updated systematic review and meta-analysis. Diabetes Metab Syndr. 2019;13(3):2300–12.

Article  PubMed  Google Scholar 

Mirzaei M, Rahmaninan M, Mirzaei M, Nadjarzadeh A, DehghaniTafti AA. Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in Central Iran: results from Yazd health study. BMC Public Health. 2020;20(1):166.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robbins JM, Strauss G, Aron D, Long J, Kuba J, Kaplan Y. Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration? J Am Podiatr Med Assoc. 2008;98(6):489–93.

Article  PubMed  Google Scholar 

Tchero H, Kangambega P, Lin L, Mukisi-Mukaza M, Brunet-Houdard S, Briatte C, et al., editors. Cost of diabetic foot in France, Spain, Italy, Germany and United Kingdom: A systematic review. Annales d'endocrinologie; 2018: Elsevier.

Syed MH, Salata K, Hussain MA, Zamzam A, de Mestral C, Wheatcroft M, et al. The economic burden of inpatient diabetic foot ulcers in Toronto. Canada Vascular. 2020;28(5):520–9.

Article  PubMed  Google Scholar 

Keskek SO, Kirim S, Yanmaz N. Estimated costs of the treatment of diabetic foot ulcers in a tertiary hospital in Turkey. Pakistan J Med Sci. 2014;30(5):968.

Google Scholar 

Senneville É, Albalawi Z, van Asten SA, Abbas ZG, Allison G, Aragón-Sánchez J, et al. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023). Diabetes Metab Res Rev. 2024;40(3):e3687.

Article  PubMed  Google Scholar 

Hazar N, Jokar M, Namavari N, Hosseini S, Rahmanian V. An updated systematic review and Meta-analysis of the prevalence of type 2 diabetes in Iran, 1996–2023. Front Public Health. 2024;12:1322072.

Article  PubMed  PubMed Central  Google Scholar 

Köster I, Schubert I, Huppertz E. Follow up of the CoDiM-Study: Cost of diabetes mellitus 2000–2009. Deutsche medizinische Wochenschrift (1946). 2012;137(19):1013–6.

Mata-Cases M, Casajuana M, Franch-Nadal J, Casellas A, Castell C, Vinagre I, et al. Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain. Eur J Health Econ. 2016;17:1001–10.

Article  PubMed  Google Scholar 

Bruno G, Picariello R, Petrelli A, Panero F, Costa G, Cavallo-Perin P, et al. Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy. Nutr Metab Cardiovasc Dis. 2012;22(8):684–90.

Article  CAS  PubMed  Google Scholar 

Rosella L, Lebenbaum M, Fitzpatrick T, O’reilly D, Wang J, Booth G, et al. Impact of diabetes on healthcare costs in a population-based cohort: a cost analysis. Diabet Med. 2016;33(3):395–403.

Article  CAS  PubMed  Google Scholar 

Association AD. Economic costs of diabetes in the US in 2012. diabetes care 2013; 36: 1033–1046. Diabetes Care. 2013;36(6):1797.

Toscano CM, Sugita TH, Rosa MQ, Pedrosa HC, Rosa RdS, Bahia LR. Annual direct medical costs of diabetic foot disease in Brazil: a cost of illness study. Intl J Environ Res Public Health. 2018;15(1):89.

Butt MD, Ong SC, Wahab MU, Rasool MF, Saleem F, Hashmi A, et al. Cost of illness analysis of type 2 diabetes mellitus: the findings from a lower-middle income country. Int J Environ Res Public Health. 2022;19(19):12611.

Article  PubMed  PubMed Central  Google Scholar 

Pham HTK, Kieu TTM, Duong TD, Van Nguyen KD, Tran NQ, Tran TH, et al. Direct medical costs of diabetes and its complications in Vietnam: A national health insurance database study. Diabetes Res Clin Pract. 2020;162:108051.

Article  Google Scholar 

Bahia LR, Araujo DV, Schaan BD, Dib SA, Negrato CA, Leão MP, et al. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system. Value in health. 2011;14(5):S137–40.

Article  PubMed  Google Scholar 

Bermudez-Tamayo C, Besançon S, Johri M, Assa S, Brown JB, Ramaiya K. Direct and indirect costs of diabetes mellitus in Mali: A case-control study. PLoS ONE. 2017;12(5):e0176128.

Article  PubMed  PubMed Central  Google Scholar 

Kieu TTM, Trinh HN, Pham HTK, Nguyen TB, Ng JYS. Direct non-medical and indirect costs of diabetes and its associated complications in Vietnam: an estimation using national health insurance claims from a cross-sectional survey. BMJ Open. 2020;10(3):e032303.

Article  PubMed  PubMed Central  Google Scholar